Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review. Issue 6 (2nd March 2020)

• Record Type: Journal Article
• Authors: Mandal, Mukesh; Jaiswal, Pawan; Mishra, Awanish
• Is Part Of: Journal of biochemical and molecular toxicology. Volume 34:Issue 6(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-03-02
• Subjects: alzheimer's diseases -- curcumin -- curcumin nanoparticle -- neurodegenerative diseases -- oxidative stress -- Parkinson's disease; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Toxicology -- Periodicals; 574
• DOI: 10.1002/jbt.22478
• Languages: English
• ISSNs: 1095-6670

Abstract

Abstract: Curcumin, a dietary polyphenol and major constituent of Curcuma longa (Zingiberaceae), is extensively used as a spice in Asian countries. For ages, turmeric has been used in traditional medicine systems to treat various diseases, which was possible because of its anti‐inflammatory, antioxidant, anticancerous, antiepileptic, antidepressant, immunomodulatory, neuroprotective, antiapoptotic, and antiproliferative effects. Curcumin has potent antioxidant, anti‐inflammatory, antiapoptotic, neurotrophic activities, which support its plausible neuroprotective effects in neurodegenerative disease. However, there is limited information available regarding the clinical efficacy of curcumin in neurodegenerative cases. The low oral bioavailability of curcumin may be speculated as a plausible factor that limits its effects in humans. Therefore, utilization of several approaches for the enhancement of bioavailability may improve clinical outcomes. Furthermore, the use of nanotechnology and a targeted drug delivery system may improve the bioavailability of curcumin. The present review is designed to summarize the molecular mechanisms pertaining to the neuroprotective effects of curcumin and its nanoformulations. Abstract : Improved Neurotherapeutics with Curcumin Nanoformulations.